TickerFactsScreenerDevelopers

MYRIAD GENETICS INC (MYGN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $237.73M2009: $63.51M2010: $92.84M2011: $52.68M2012: $86.40M2013: $104.10M2014: $64.80M2015: $64.10M2016: $68.50M2017: $102.40M2018: $110.90M2019: $93.20M2020: $117.00M2021: $257.40M2022: $56.90M2023: $132.10M2024: $102.40M2025: $149.60M$149.60M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$149.60M+46.1%
2024$102.40M-22.5%
2023$132.10M+132.2%
2022$56.90M-77.9%
2021$257.40M+120.0%
2020$117.00M+25.5%
2019$93.20M-16.0%
2018$110.90M+8.3%
2017$102.40M+49.5%
2016$68.50M+6.9%
2015$64.10M-1.1%
2014$64.80M-37.8%
2013$104.10M+20.5%
2012$86.40M+64.0%
2011$52.68M-43.3%
2010$92.84M+46.2%
2009$63.51M-73.3%
2008$237.73M—